Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01486043 · ClinicalTrials.gov registry record · NA
Metformin and Transient Hyperglycemia
A NA study, sponsored by Children's Hospital Los Angeles.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01486043 is a NA study that was terminated before completion, run by Children's Hospital Los Angeles. The registered enrollment target is 4 participants.
The verdict
NCT01486043, a NA study, was terminated before completion, sponsored by Children's Hospital Los Angeles.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether metformin is an effective adjunctive treatment for transient hyperglycemia in patients with acute lymphoblastic leukemia (ALL) undergoing induction chemotherapy
Interventions
- DRUG Metformin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01486043
The ClinicalTrials.gov registry entry for NCT01486043 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metformin is the first listed.
NCT01486043 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01486043 about?
NCT01486043 is a clinical study titled "Metformin and Transient Hyperglycemia". The purpose of this study is to determine whether metformin is an effective adjunctive treatment for transient hyperglycemia in patients with acute lymphoblastic leukemia (ALL) undergoing induction chemotherapy
What is the current status of trial NCT01486043?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2011-12. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01486043?
The interventions under investigation include: Metformin (DRUG).
Who is sponsoring clinical trial NCT01486043?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.